These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7870687)
1. In vitro and in vivo evaluation in dogs and pigs of a hydrophilic matrix containing propylthiouracil. Kabanda L; Lefebvre RA; Van Bree HJ; Remon JP Pharm Res; 1994 Nov; 11(11):1663-8. PubMed ID: 7870687 [TBL] [Abstract][Full Text] [Related]
2. In-vivo evaluation in man of a hydrophilic matrix containing propylthiouracil. Kabanda L; Lefebvre RA; Remon JP J Pharm Pharmacol; 1996 Oct; 48(10):1023-6. PubMed ID: 8953503 [TBL] [Abstract][Full Text] [Related]
3. In vitro/in vivo evaluation of two series of TA-5707F controlled release matrix tablets prepared with hydroxypropyl methyl cellulose derivatives with entero-soluble or gel-formation properties. Yamakita H; Maejima T; Osawa T Biol Pharm Bull; 1995 Oct; 18(10):1409-16. PubMed ID: 8593447 [TBL] [Abstract][Full Text] [Related]
4. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures. Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867 [TBL] [Abstract][Full Text] [Related]
5. Influence of water soluble fillers in hydroxypropylmethylcellulose matrices on in vitro and in vivo drug release. Sako K; Sawada T; Nakashima H; Yokohama S; Sonobe T J Control Release; 2002 May; 81(1-2):165-72. PubMed ID: 11992689 [TBL] [Abstract][Full Text] [Related]
6. Prolonged-release hydroxypropyl methylcellulose matrix tablets of furosemide for administration to dogs. Smal J; Marvola M; Liljequist C; Happonen I J Vet Pharmacol Ther; 1996 Dec; 19(6):482-7. PubMed ID: 8971678 [TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of gastroretentive norfloxacin floating tablets. Bomma R; Swamy Naidu RA; Yamsani MR; Veerabrahma K Acta Pharm; 2009 Jun; 59(2):211-21. PubMed ID: 19564145 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies on HPMC-K-100 M matrices containing naproxen sodium. Kumar SM; Chandrasekar MJ; Gopinath R; Srinivasan R; Nanjan MJ; Suresh B Drug Deliv; 2007 Mar; 14(3):163-9. PubMed ID: 17454036 [TBL] [Abstract][Full Text] [Related]
9. Matrix polymeric excipients: comparing a novel interpolyelectrolyte complex with hydroxypropylmethylcellulose. Lu Z; Chen W; Olivier E; Hamman JH Drug Deliv; 2008 Feb; 15(2):87-96. PubMed ID: 18293194 [TBL] [Abstract][Full Text] [Related]
10. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation. Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518 [TBL] [Abstract][Full Text] [Related]
11. Development of a controlled release formulation by continuous twin screw granulation: Influence of process and formulation parameters. Vanhoorne V; Vanbillemont B; Vercruysse J; De Leersnyder F; Gomes P; Beer TD; Remon JP; Vervaet C Int J Pharm; 2016 May; 505(1-2):61-8. PubMed ID: 27041123 [TBL] [Abstract][Full Text] [Related]
12. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet. Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912 [TBL] [Abstract][Full Text] [Related]
13. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release. Hiremath PS; Saha RN Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928 [TBL] [Abstract][Full Text] [Related]
14. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3. Franek F; Holm P; Larsen F; Steffansen B Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet. Tamilvanan S; Venkatesh Babu R; Nappinai A; Sivaramakrishnan G Drug Dev Ind Pharm; 2011 Apr; 37(4):436-45. PubMed ID: 20923389 [TBL] [Abstract][Full Text] [Related]
16. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen. Cao QR; Choi YW; Cui JH; Lee BJ J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656 [TBL] [Abstract][Full Text] [Related]
17. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs]. Li CJ; Yu YL; Yang QM; Li Y; Zhang YH; Wang JY Yao Xue Xue Bao; 2010 Sep; 45(9):1170-6. PubMed ID: 21351575 [TBL] [Abstract][Full Text] [Related]
18. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis. Ferrero C; Massuelle D; Doelker E J Control Release; 2010 Jan; 141(2):223-33. PubMed ID: 19766681 [TBL] [Abstract][Full Text] [Related]
19. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus. Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets. Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]